M&T Bank Corp Files Restated Q1 2026 Form 13F Reporting $30.53B in Holdings

Executive Summary

On September 4, 2026, M&T BANK CORP (CIK: 0000036270) filed Form 13F-HR/A (Amendment No. 1 - Restatement) covering the reporting period ending March 31, 2026.

Key Filing Metrics

• Filing Type: Form 13F Holdings Report Amendment (Restatement)
• Period of Report: Q1 2026 (2026-03-31)
• Total Portfolio Value Reported: $30,531,813,796 (~$30.53 Billion)
• Total Table Entries: 13,689
• Other Included Managers Count: 7

Included Institutional Managers

The report consolidates investment holdings across M&T Bank Corporation and its asset management subsidiaries:

1. Manufacturers & Traders Trust Company (028-03980)
2. Wilmington Trust Investment Advisors, Inc. (028-10909)
3. Wilmington Trust National Association (028-14686)
4. Wilmington Trust Company (028-03742)
5. Wilmington Funds Management Corp (028-06601)
6. Wilmington Trust Investment Management, LLC (028-12629)
7. Wilmington Trust Asset Management, LLC (028-23418)

Sample Holdings in Filing Text

Notable holdings detailed in the excerpt include positions in:

• Accenture PLC (G1151C101)
• AstraZeneca PLC (G0593M107)
• Eaton Corp PLC (G29183103)
• TotalEnergies SE (F92124100)
• Aon PLC (G0403H108)
• Arch Capital Group Ltd. (G0450A105)
• CRH PLC (G25508105)
• Aptiv PLC (G3265R107)
• FTAI Aviation Ltd. (G3730V105)
• Fabrinet (G3323L100)